Accessibility Menu
 
BioSyent logo

BioSyent

(OTC) BIOYF

Current Price$11.24
Market Cap$128.98M
Since IPO (2012)+2,106%
5 Year+103%
1 Year+46%
1 Month+4%

BioSyent Financials at a Glance

Market Cap

$128.98M

Revenue (TTM)

$43.04M

Net Income (TTM)

$9.01M

EPS (TTM)

$0.56

P/E Ratio

19.62

Dividend

$0.15

Beta (Volatility)

0.19 (Low)

Price

$11.24

Volume

4,774

Open

$11.24

Previous Close

$11.24

Daily Range

$11.12 - $11.25

52-Week Range

$6.49 - $12.00

BIOYF News

No articles available.

BIOYF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioSyent

Industry

Pharmaceuticals

Employees

60

CEO

René C. Goehrum

Headquarters

Mississauga, ON L5N 6M1, CA

BIOYF Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

26%

Net Income Margin

21%

Return on Equity

24%

Return on Capital

27%

Return on Assets

18%

Earnings Yield

5.10%

Dividend Yield

0.01%

Payout Ratio

24.99%

Stock Overview

Market Cap

$128.98M

Shares Outstanding

11.48M

Volume

4.77K

Short Interest

0.00%

Avg. Volume

2.06K

Financials (TTM)

Gross Profit

$32.08M

Operating Income

$11.30M

EBITDA

$12.16M

Operating Cash Flow

$9.61M

Capital Expenditure

$54.00K

Free Cash Flow

$9.56M

Cash & ST Invst.

$28.63M

Total Debt

$840.41K

BioSyent Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$9.66M

+9.9%

Gross Profit

$7.21M

+0.8%

Gross Margin

74.65%

N/A

Market Cap

$128.98M

N/A

Market Cap/Employee

$2.15M

N/A

Employees

60

N/A

Net Income

$1.99M

+23.4%

EBITDA

$2.61M

+4.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$27.79M

+86.5%

Accounts Receivable

$4.53M

+51.4%

Inventory

$6.41M

+20.3%

Long Term Debt

$626.23K

-25.5%

Short Term Debt

$214.18K

+8.9%

Return on Assets

18.23%

N/A

Return on Invested Capital

26.90%

N/A

Free Cash Flow

$3.80M

+45.9%

Operating Cash Flow

$3.82M

+45.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LOVFFCannara Biotech Inc.
$1.32-0.75%
MSCLFSatellos Bioscience Inc.
$8.01+11.25%
SPHRYStarpharma Holdings Limited
$3.23-2.12%
SHIEFShield Therapeutics plc
$0.14+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$172.70-0.03%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About BIOYF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.